Lee Ainslie - Maverick Capital
Holding/activity history for NewAmsterdam Pharma Co. N.V. (NAMS)
← All NAMS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,186,402 | 0.81 | Add 15.42% | 0.11 | $28.53–37.76 · VW $32.39i | $69,986,728 | SEC |
| 2025 Q4 | 1,894,226 | 0.71 | Add 25.88% | 0.15 | $31.00–42.00 · VW $36.90i | $66,449,448 | SEC |
| 2025 Q3 | 1,504,747 | 0.57 | Reduce 1.77% | <0.01 | $19.22–31.81 · VW $24.80i | $42,795,005 | SEC |
| 2025 Q2 | 1,531,874 | 0.43 | Add 178.79% | 0.28 | $14.06–22.25 · VW $18.40i | $27,742,238 | SEC |
| 2025 Q1 | 549,469 | 0.20 | Add 56.99% | 0.07 | $15.43–26.70 · VW $21.63i | $11,247,630 | SEC |
| 2024 Q4 | 350,005 | 0.16 | Buy | 0.16 | $16.51–27.29 · VW $22.65i | $8,995,129 | SEC |
Price snapshot:
Current price$33.28
Avg. buy price$24.40
+/- since buy36.42%
52-week low$20.53
52-week high$42.21